☆Tri Locum Partners LP
Quality Q
0.296
AUM ($M)
813
Positions
19
Turnover
0.38
Top-10 wt
80%
Herfindahl
0.078
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 22 positions · portfolio value $813M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆JNJ funds › | JOHNSON & JOHNSON | ADD | — | 13.3% | -0.9% | 107.9 | 424,945 | +10,442 | 4 | — |
| ☆VRTX funds › | VERTEX PHARMACEUTICALS INC | ADD | — | 12.3% | +4.2% | 100.2 | 201,791 | +72,477 | 2 | — |
| ☆LLY funds › | ELI LILLY & CO | ADD | — | 11.3% | +3.3% | 91.8 | 76,532 | +14,737 | 3 | — |
| ☆ASND funds › | ASCENDIS PHARMA A/S | NEW | — | 8.5% | +8.5% | 69.0 | 258,740 | +258,740 | 1 | — |
| ☆DXCM funds › | DEXCOM INC | ADD | — | 6.8% | +0.6% | 55.3 | 820,479 | +122,321 | 3 | — |
| ☆AXSM funds › | AXSOME THERAPEUTICS INC. | ADD | — | 6.6% | +5.1% | 53.7 | 219,308 | +157,192 | 5 | — |
| ☆JAZZ funds › | JAZZ PHARMACEUTICALS PLC | ADD | — | 6.6% | +2.4% | 53.4 | 221,720 | +63,057 | 2 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | NEW | — | 5.4% | +5.4% | 44.0 | 866,716 | +866,716 | 1 | — |
| ☆ARGX funds › | ARGENX SE | ADD | — | 4.7% | +1.5% | 38.6 | 41,596 | +9,961 | 5 | — |
| ☆MDGL funds › | MADRIGAL PHARMACEUTICALS INC | TRIM | — | 4.5% | -3.1% | 36.7 | 68,273 | -35,015 | 5 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | NEW | — | 3.5% | +3.5% | 28.4 | 151,822 | +151,822 | 1 | — |
| ☆UTHR funds › | UNITED THERAPEUTICS CORP DEL | TRIM | — | 3.1% | -2.7% | 25.5 | 47,026 | -23,344 | 4 | — |
| ☆TEVA funds › | TEVA PHARMACEUTICAL INDS LTD | TRIM | — | 3.1% | -1.2% | 25.3 | 746,835 | -274,173 | 3 | — |
| ☆TARS funds › | TARSUS PHARMACEUTICALS INC | ADD | — | 2.5% | +0.1% | 20.7 | 328,340 | +75,752 | 2 | — |
| ☆ISRG funds › | INTUITIVE SURGICAL INC | TRIM | — | 2.3% | -7.6% | 19.1 | 47,983 | -105,267 | 2 | — |
| ☆CYTK funds › | CYTOKINETICS INC | NEW | — | 2.0% | +2.0% | 16.5 | 194,000 | +194,000 | 1 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | TRIM | — | 1.4% | -0.3% | 11.8 | 120,712 | -24,831 | 4 | — |
| ☆BBNX funds › | BETA BIONICS INC | NEW | — | 1.0% | +1.0% | 7.7 | 493,344 | +493,344 | 1 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | TRIM | — | 0.9% | -0.0% | 7.7 | 162,996 | -206,592 | 2 | — |
| ☆NUVL funds › | NUVALENT INC | EXIT | — | 0.0% | -4.4% | 0.0 | 0 | -308,506 | 0 | — |
| ☆CUSIP:04351P101 funds › | ASCENDIS PHARMA A/S | EXIT | — | 0.0% | -8.2% | 0.0 | 0 | -255,332 | 0 | — |
| ☆TMO funds › | THERMO FISHER SCIENTIFIC INC | EXIT | — | 0.0% | -9.1% | 0.0 | 0 | -132,413 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 813 | 19 | 0.38 | 80% | 0.078 | 0.296 | — | in |
| 2026Q1 | 713 | 17 | 0.40 | 82% | 0.079 | 0.282 | — | in |
| 2025Q4 | 770 | 15 | 0.50 | 80% | 0.082 | 0.112 | — | in |
| 2025Q3 | 435 | 18 | 0.53 | 84% | 0.079 | 0.074 | — | in |
| 2025Q2 | 330 | 23 | 0.50 | 74% | 0.064 | 0.066 | — | entered |
| 2025Q1 | 195 | 22 | 0.00 | 73% | 0.066 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status